• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有S-100蛋白免疫反应性的乳腺癌。一项免疫细胞化学和超微结构研究。

Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.

作者信息

Lunde S, Nesland J M, Holm R, Johannessen J V

机构信息

Department of Pathology, Norwegian Radium Hospital and Institute for Cancer Research, Oslo.

出版信息

Pathol Res Pract. 1987 Oct;182(5):627-31.

PMID:2825146
Abstract

Protein S-100 immunoreactivity was observed in 5 of 50 breast carcinomas (3 infiltrating lobular and 2 infiltrating ductal carcinomas). A diffuse cytoplasmic staining was present in single cells and groups of cells. The majority of normal myoepithelial cells in ducts of unremarkable appearance next to tumor areas were stained in all 50 breast carcinomas. The 5 protein S-100 positive tumors all stained for prekeratin and 4 of them were vimentin-positive. No immunoreactivity for actin or NSE was observed in the 5 tumors. Electron microscopy did not distinguish the protein S-100 positive carcinomas from the 45 protein S-100 negative tumors. The significance of protein S-100 immunostaining in breast carcinomas is discussed.

摘要

在50例乳腺癌中,有5例(3例浸润性小叶癌和2例浸润性导管癌)观察到S-100蛋白免疫反应性。单个细胞和细胞群中存在弥漫性细胞质染色。在所有50例乳腺癌中,肿瘤区域旁外观正常的导管中的大多数正常肌上皮细胞均被染色。5例S-100蛋白阳性肿瘤均对角蛋白染色,其中4例波形蛋白阳性。在这5例肿瘤中未观察到肌动蛋白或神经元特异性烯醇化酶的免疫反应性。电子显微镜无法区分5例S-100蛋白阳性癌与45例S-100蛋白阴性肿瘤。文中讨论了S-100蛋白免疫染色在乳腺癌中的意义。

相似文献

1
Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.具有S-100蛋白免疫反应性的乳腺癌。一项免疫细胞化学和超微结构研究。
Pathol Res Pract. 1987 Oct;182(5):627-31.
2
S100 protein in human mammary tissue--immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and value as a marker of myoepithelial cells.人乳腺组织中的S100蛋白——在乳腺癌(包括乳头派杰病)中的免疫反应性及其作为肌上皮细胞标志物的价值。
J Pathol. 1990 Jan;160(1):19-24. doi: 10.1002/path.1711600106.
3
[Ductal carcinoma of the breast. Electron microscopic study].[乳腺导管癌。电子显微镜研究]
Patol Pol. 1989;40(2):171-9.
4
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.细胞周期蛋白D1(PRAD1)在乳腺癌中的蛋白表达:约三分之一的浸润性乳腺癌显示细胞周期蛋白D1癌基因过表达。
Mod Pathol. 1995 Jun;8(5):560-7.
5
Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?在考虑对乳腺癌进行新辅助化疗时,是否应考虑组织学类型?
Breast J. 2009 Mar-Apr;15(2):146-54. doi: 10.1111/j.1524-4741.2009.00689.x.
6
Estrogen and progesterone receptors in primary eccrine carcinoma.原发性小汗腺癌中的雌激素和孕激素受体
Mod Pathol. 1991 Sep;4(5):582-5.
7
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.微小腺腺病及向原位癌和浸润癌转变的临床、组织病理学及免疫组化特征。
Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.
8
An ultrastructural study of benign and malignant breast epithelial cells. A search for tonofilaments.
J Submicrosc Cytol Pathol. 1989 Jul;21(3):469-74.
9
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.乳腺导管癌中雌激素受体、孕激素受体及c-erbB2癌基因蛋白表达的改变
Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.
10
Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.P-钙黏蛋白在乳腺癌中的异常表达。与E-钙黏蛋白表达及病理特征的相关性。
Am J Pathol. 1995 Mar;146(3):605-12.

引用本文的文献

1
Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
Virchows Arch A Pathol Anat Histopathol. 1992;421(5):435-42. doi: 10.1007/BF01606917.